The FDA has approved an update to the prescribing information for Merck‘s PAH treatment Winrevair (sotatercept-csrk).

PAH has increased worldwide in older adults, largely due to growing aging populations, with the greatest risk factors in ...

Pulmonary hypertension treatment can help slow disease progression, ease symptoms, and improve quality of life for people with the disease.

The term "October slide" refers to a trend in which many in the chronic illness community face health setbacks, writes ...

Time is a precious commodity, says columnist Jolie Lizana, who spends too many hours each month managing her health with PH.

Anticoagulant therapy does not extend survival in people with PAH, according to a French study involving the blood thinners.

Researchers developed PVC, a measure that estimates the reduced function of the pulmonary arteries in pediatric PAH patients, per a study.

The strategy begins with medications, followed by balloon pulmonary angioplasty, and pulmonary endarterectomy surgery, a ...

Long-term treatment with Tyvaso DPI is safe and effective in adults with PAH who were previously on Tyvaso, according to ...

A new experimental therapy for pulmonary arterial hypertension (PAH), called ALG-801, has shown superior efficacy over current standard-of-care treatments in early laboratory studies, according to its ...